Hypogonadism Completed Phase 2 Trials for Enclomiphene (DB06735)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01386567A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203Treatment